Showing results (1-10 of 136) with videos related to
Sort By:
Pageof 14
Atherosclerosis|April 1, 1989
Platelet activation by oxidatively modified low density lipoproteinsN G Ardlie, M L Selley, L A SimonsThrombosis Research|September 15, 1996
The effect of cholesterol oxidation products on human platelet aggregationM L Selley, J A McGuiness, N G ArdlieAtherosclerosis|September 11, 1998
The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and ironM L Selley, M R Bartlett, A L Czeti, et al.Chemico-Biological Interactions|January 1, 1990
Effects of acrolein on human platelet aggregationM L Selley, M R Bartlett, J A McGuiness, et al.Atherosclerosis|November 1, 1994
Dipyridamole inhibits the oxidative modification of low density lipoproteinM L Selley, A L Czeti, J A McGuiness, et al.Arzneimittel-Forschung|March 1, 1992
Effect of anethole dithiolthione on human platelet aggregationM L Selley, J A McGuiness, M R Bartlett, et al.Journal of Chromatography|March 24, 1989
Determination of the lipid peroxidation product trans-4-hydroxy-2-nonenal in biological samples by high-performance liquid chromatography and combined capillary column gas chromatography-negative-ion chemical ionisation mass spectrometryM L Selley, M R Bartlett, J A McGuiness, et al.Thrombosis and Haemostasis|April 8, 1988
Effect of 4-hydroxy-2,3-trans-nonenal on platelet functionM L Selley, J A McGuiness, L A Jenkin, et al.Journal of Reproduction and Fertility|July 1, 1991
Content of significant amounts of a cytotoxic end-product of lipid peroxidation in human semenM L Selley, M J Lacey, M R Bartlett, et al.Annals of the Rheumatic Diseases|April 1, 1992
Occurrence of (E)-4-hydroxy-2-nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritisM L Selley, D J Bourne, M R Bartlett, et al.Pageof 14